Dr. Ross Discusses the Future Treatment Landscape of Melanoma

Video

Merrick I. Ross, MD, professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses the future treatment landscape of melanoma.

Merrick I. Ross, MD, professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses the future treatment landscape of melanoma.

The landscape of melanoma moving forward is multi-faceted, says Ross, particularly with neoadjuvant therapies.

Related Videos
Laura J. Chambers, DO
Casey M. Cosgrove, MD
Vaidehi Mujumdar, MD
Hua-Jay "Jeff" Cherng, MD
Joseph G. Jurcic, MD
Kathryn Beckermann, MD, PhD
Sunil Iyer, MD
Erin Crane, MD, MPH
Ibrahim Aldoss, MD
Minoo Battiwalla, MD
Related Content
Melanoma | Image Credit: © SciePro - stock.adobe.com

Adjuvant Multipeptide Vaccine Combination Prolongs Survival in Melanoma

May 2nd 2024
Article
Jeffrey S. Weber, MD, PhD

FDA Approval Insights: Adjuvant Nivolumab in Completely Resected Stage IIB/C Melanoma

November 6th 2023
Podcast
Zeynep Eroglu, MD, Moffitt Cancer Center

Toxicities Hinder Potential Efficacy of Ceritinib/Trametinib in Pretreated Advanced Melanoma

April 26th 2024
Article
Nikhil I. Khushalani, MD; Martin F. Dietrich, MD, PhD; Jason J. Luke, MD, FACP; Vishal A. Patel, MD, FAAD, FACMS

CSCC Experts Discuss Considerations for Determining Resectable Disease and Translating Data Into Practice

March 6th 2023
Podcast
Udai Kammula, MD, FACS

Uveal Melanoma Immunogenomic Score Shows Predictive Potential

April 23rd 2024
Article
Professor Lindy Durrant

SCIB1 Plus Nivolumab/Ipilimumab Generates ORR of 85% in Advanced Unresectable Melanoma

April 22nd 2024
Article